CTRI/2019/06/019539已完成未知
A multi-centric study of reversal of type2 diabetes and pre-diabetes by Dixitâ??s 2-meal and exercise lifestyle intervention: A three arm prospective retrospective comparative cohort hybrid study in Maharashtra using HbA1C as main diagnostic criterion. - 2-OMEX
Bharat vaidyaka sanstha0 个研究点目标入组 500 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •T2Diabetes with HbA1C >6.5gm%,
- •T2D duration between 1-10 yrs,
- •On oral antidiabetic medication,
- •Age between 30-70 yrs,
- •Availability of back records of HbA1C in last 12 months-atleast two readings
- •currently on2-OMEX lifestyle >2 weeks
- •Has completed minimum first 3 once-monthly visits (hence 3months) at DRC (diabetes Reversal centers) and following 2-OMEX lifestyle
- •(For arm2-prediabetic, HbA1C between 5.6to 6.4, following 2-OMEX lifestyle)
- •(For Arm3, just as Arm1except that he/she is following conventional management under physician with small frequent meals.
- •Exclusion: patient on Insulin medication, ongoing complications of heart, liver, kidneys, (with appropriate tests) alcohol addiction, cannot tolerate 2-OMEX
排除标准
- •Patient on Insulin medication, ongoing complications of heart, liver, kidneys, (with appropriate tests) alcohol addiction, cannot tolerate 2-OMEX
研究者
相似试验
撤回
不适用
Effect evaluation of Reverse diabetes type 2 program by Voeding LeeftDiabetes mellitusNL-OMON45893ouis Bolk Instituut300
已完成
不适用
Diabetes Remission Clinical TrialType 2 diabetesNutritional, Metabolic, EndocrineType 2 diabetes mellitusISRCTN03267836HS Greater Glasgow and Clyde (UK)306
已完成
不适用
DOORS: A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes Who Change From Dipeptidyl Peptidase-4 Inhibitor (DPP4i) Treatment to Oral Semaglutide in ItalyDiabetes Mellitus, Type 2NCT05755360Novo Nordisk A/S291
进行中（未招募）
不适用
A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes in IndiaDiabetes Mellitus, Type 2NCT05502562Novo Nordisk A/S388
招募中
不适用
Multicenter Investigation for Diabetes mellitus in AtheroSclerosisPatients admitted to the participating institution for 1. Acute myocardial infarction within 24 hours after symptom onset 2. Angina pectoris requiring PCI 3. Heart failure 4. Atrial fibrillation undergoing catheter ablation 5. Cerebral infarction 6. Transient ischemic attackJPRN-UMIN000010039ational Cerebral and Cardiovascular Center5,000